Providers and patients fish for that delicate balance between access and abandonment.
An answer to your question: What does the Part D coverage gap do to drug sales?
Dual eligibles have less access to top brands than they did before
the launch of Part D
How Digital Medicine Can Pinpoint Dosing Regimens to Optimize Drug Efficacy and Safety
Sponsored By Oracle
Multi-faceted Approaches to Meet Payer and Regulatory Evidence Requirements
Sponsored By UBC Express Scripts
Overcoming the Life Sciences Content Conundrum in a Multichannel World
Sponsored By Veeva